Armata Pharmaceuticals (ARMP) Shareholder's Equity Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -151.36% |
| Dec 31, 2025 | -100.49% |
| Sep 30, 2025 | -60.02% |
| Jun 30, 2025 | -48.94% |
| Mar 31, 2025 | -42.18% |
| Dec 31, 2024 | -57.28% |
| Sep 30, 2024 | -60.65% |
| Jun 30, 2024 | -53.42% |
| Mar 31, 2024 | -54.13% |
| Dec 31, 2023 | -54.67% |
| Sep 30, 2023 | -35.78% |
| Jun 30, 2023 | -13.56% |
| Mar 31, 2023 | -12.48% |
| Dec 31, 2022 | 35.22% |
| Sep 30, 2022 | 35.97% |
| Jun 30, 2022 | 33.05% |
| Mar 31, 2022 | 149.65% |
| Dec 31, 2021 | 48.89% |
| Sep 30, 2021 | 39.26% |
| Jun 30, 2021 | 35.28% |
| Mar 31, 2021 | 32.24% |
| Dec 31, 2020 | -8.16% |
| Sep 30, 2020 | 36.14% |
| Jun 30, 2020 | 44.31% |
| Mar 31, 2020 | 71.41% |
| Dec 31, 2019 | 14.49% |
| Sep 30, 2019 | -0.18% |
| Jun 30, 2019 | 1.74% |
| Mar 31, 2019 | -23.68% |
| Dec 31, 2018 | -15.42% |
| Sep 30, 2018 | -17.50% |
| Jun 30, 2018 | -4.06% |
| Mar 31, 2018 | 89.28% |
| Dec 31, 2017 | 92.04% |
| Sep 30, 2017 | 30.72% |
| Jun 30, 2017 | 36.62% |
| Mar 31, 2017 | 29.97% |
| Dec 31, 2016 | 34.44% |